Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?

BACKGROUND: Acinetobacter baumannii has been recognized as a cause of nosocomial infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A. baumannii (CRAB). Thus, the small number of effective antibiotic options against CRAB represents a challenge to human health...

Descripción completa

Detalles Bibliográficos
Autores principales: Saelim, Weerayuth, Changpradub, Dhitiwat, Thunyaharn, Sudaluck, Juntanawiwat, Piraporn, Nulsopapon, Parnrada, Santimaleeworagun, Wichai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032916/
https://www.ncbi.nlm.nih.gov/pubmed/34409786
http://dx.doi.org/10.3947/ic.2021.0007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032916/
https://www.ncbi.nlm.nih.gov/pubmed/34409786
http://dx.doi.org/10.3947/ic.2021.0007

Ejemplares similares